A Proof-of-Concept Study on Bioelectric-Based Biosensing for Prostate-Specific Antigen Detection in Serum Samples
Open Access
- 3 August 2025
- journal article
- research article
- Published by MDPI AG in Biosensors
- Vol. 15 (8) , 503
Abstract
Prostate cancer is among the most prevalent malignancies in men worldwide, underscoring the need for early and accurate diagnostic tools. This study presents a proof-of-concept and pilot clinical validation of a novel bioelectric impedance-based biosensor for the detection of prostate-specific antigen (PSA) in human serum. The system integrates Molecular Identification through Membrane Engineering (MIME) with the xCELLigence real-time cell analysis platform, employing Vero cells electroinserted with anti-PSA antibodies. Optimization experiments identified 15,000 cells/well as the optimal configuration for impedance response. The biosensor exhibited specific, concentration-dependent changes in impedance upon exposure to PSA standard solutions and demonstrated significant differentiation between PSA-positive and PSA-negative human serum samples relative to the clinical threshold of 4 ng/mL. The biosensor offered rapid results within one minute, unlike standard immunoradiometric assay (IRMA), while showing strong diagnostic agreement. The system’s specificity, sensitivity, and reproducibility support its potential for integration into point-of-care screening workflows. This bioelectric assay represents one of the fastest PSA detection approaches reported to date and offers a promising solution for reducing overdiagnosis while improving clinical decision-making and patient outcomes.Keywords
This publication has 48 references indexed in Scilit:
- Portable Colorimetric Sensor Array Based on a Porous Single‐Atom Fe Nanozyme with Different Surface Sites for Identifying Artificially Ripened FruitsAdvanced Functional Materials, 2024
- Nanomaterials‐Based Biosensors for the Detection of Prostate Cancer Biomarkers: Recent Trends and Future PerspectiveAdvanced Materials Technologies, 2023
- Understanding of PSA biology, factors affecting PSA detection, challenges, various biomarkers, methods, and future perspective of prostate cancer detection and diagnosisAdvances in Cancer Biology - Metastasis, 2022
- Advanced nanoengineered—customized point-of-care tools for prostate-specific antigenMicrochimica Acta, 2021
- Sensors for diagnosis of prostate cancer: Looking beyond the prostate specific antigenBiosensors and Bioelectronics, 2021
- Nanomaterial based aptasensing of prostate specific antigen (PSA): Recent progress and challenges in efficient diagnosis of prostate cancer using biomedicineBiomedicine & Pharmacotherapy, 2020
- A modern era of personalized medicine in the diagnosis, prognosis, and treatment of prostate cancerComputers in Biology and Medicine, 2020
- Label-free electrochemical impedance biosensor to detect human interleukin-8 in serum with sub-pg/ml sensitivityBiosensors and Bioelectronics, 2016
- Visualization of the membrane engineering concept: evidence for the specific orientation of electroinserted antibodies and selective binding of target analytesJournal of Molecular Recognition, 2013
- Power-free chip enzyme immunoassay for detection of prostate specific antigen (PSA) in serumBiosensors and Bioelectronics, 2013